Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement

Immunity

Volumn 6, Issue 4, 1997, Pages 411-417

  Perez, Victor L ^a,c   Van Parijs, Luk ^a   Biuckians, Andre ^a   Zheng, Xin Xiao ^b   Strom, Terry B ^b   Abbas, Abul K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030966217     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80284-8     Document Type: Article

References (30)

1. L. Immunity, 3, 87-98.
2. Freeman, G.J., Borriello, F., Hodes, R.J., Reiser, H., Hathcock, K.S., Laszlo, G., McKnight, A.J., Kim, J., Du, L., Lombard, D.B., et al. (1993). Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262, 907-909.
3. Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J., and Marrack, P. (1983). The MHC-restricted antigen receptor on T cells. I. Isolation of a monoclonal antibody. J. Exp. Med. 157, 1149-1169.
4. Jenkins, M.K. (1994). The ups and downs of T cell costimulation. Immunity 1, 443-446.
5. Karandikar, N.J., Vanderlugt, C.L., Walunas, T.L., Miller, S.D., and Bluestone, J.A. (1996). CTLA-4: A negative regulator of autoimmune disease. J. Exp. Med. 184, 783-788.
6. Kearney, E.R., Pape, K.A., Loh, D.Y., and Jenkins, M.K. (1994). Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339.
7. Kearney, E.R., Walunas, T.L., Karr, R.W., Morton, P.A., Loh, D.Y., Bluestone, J.A., and Jenkins, M.K. (1995). Antigen-dependent clonal expansion of a trace population of antigen-specific CD4 T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155, 1032-1036.
8. Krummel, M.F., and Allison, J.P. (1995). CD28 and CTLA-4 have opposing effects on the responses of T cells to stimulation. J. Exp. Med. 182, 459-465.
9. Krummel, M.F., and Allison, J.P. (1996). CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540.
10. Leach, D.R., Krummel, M.F., and Allison, J.P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736.
11. Lenschow, D.J., Zeng, Y., Thistlethwaite, J.R., Montag, A., Brady, W., Gibson, M.G., Linsley, P.S., and Bluestone, J.A. (1992). Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-41g. Science 257, 789-792.
12. Lenschow, D.J., Zeng, Y., Hathcock, K.S., Zuckerman, L.A., Freeman, G., Thistlehwaite, J.R., Gray, G.S., Hodes, R.J., and Bluestone, J.A. (1995). Inhibition of transplanted rejection following treatment with anti-B7-2 and B7-1 antibodies. Transplantation 60, 1171-1178.
13. Lin, H., Bolling, S.F., Linsley, P.S., Wei, R.Q., Gordon, D., Thompson, C.B., and Turka, L.A. (1993). Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA41g plus donor-specific transfusions. J. Exp. Med. 178, 1801-1806.
14. Linsley, P.S. (1995). Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation. J. Exp. Med. 182, 289-292.
15. Linsley, P.S., Wallace, P.M., Johnson, J., Gibson, M.G., Greene, J.L., Ledbetter, J.A., Singh, C., and Tepper, M.A. (1992). Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation model. Science 257, 792-795.
16. Lucas, P.J., Negishi, I., Nakayama, K., Fields, L.E., and Loh, D.Y. (1995). Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154, 5757-5768.
17. Miller, J.F.A.P., and Flavell, R.A. (1994). T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. Curr. Opin. Immunol. 6, 892-899.
18. Mueller, D.L., Jenkins, M.K., and Schwartz, R.H. (1989). Clonal expansion versus functional clonal activation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-480.
19. lo thymocytes in vivo. Science 250, 1720-1723.
20. Ohashi, P.S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C.T., Odermatt, B., Malissen, B., Zinkernagel, R.M., and Hengartner, H. (1991). Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65, 305-317.
21. Perez, V.L., Lederer, J.A., Lichtman, A.H., and Abbas, A.K. (1994). Stability of Th1 and Th2 populations. Int. Immunol. 7, 869-875.
22. Perrin, P.J., Maldonado, J.H., Davis, T.A., June, C.H., and Racke, M.K. (1996). CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157, 1333-1336.
23. Sayegh, M.H., Akalin, E., Hancock, W.W., Russell, M.E., Carpenter, C.B., Linsley, P.S., and Turka, L.A. (1995). CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but sparesTh2. J. Exp. Med. 181, 1869-1874.
24. Schwartz, R.H. (1990). A cell culture model for T lymphocyte clonal anergy. Science 248, 1349-1356.
25. Steurer, W., Nickerson, P.W., Steele, A.W., Steiger, J., Zheng, X.X., and Strom, T.B. (1995). Ex vivo coating of islet cell allograft with murine CTLA4/Fc promotes graft tolerance. J. Immunol. 155, 1165-1174.
26. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
27. Van Parijs, L., Ibraghimov, A., and Abbas, A.K. (1996). The roles of costimulation and fas in T cell apoptosis and peripheral tolerance. Immunity 4, 321-328.
28. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B., and Bluestone, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
29. Walunas, T.L., Bakker, C.Y., and Bluestone, J.A. (1996). CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550.
30. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988.